These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8513090)

  • 1. [Amylin: its potential role in the etiopathogenicity of diabetes mellitus].
    Artozqui Morrás E; Botella Serrano M; Camblor M; Bretón Lesmes I; Moreno Esteban B
    An Med Interna; 1993 Apr; 10(4):200-2. PubMed ID: 8513090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of IAPP in the pathogenesis and development of NIDDM].
    Sanke T; Nishi M; Nanjo K
    Nihon Rinsho; 1994 Oct; 52(10):2737-45. PubMed ID: 7983807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of amylin in the pathogenesis of type II diabetes mellitus].
    Prager R; Ludvik B; Hartter E
    Acta Med Austriaca; 1991; 18(3):61-2. PubMed ID: 1950379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "A" is for amylin and amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
    Jaikaran ET; Nilsson MR; Clark A
    Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
    Kapurniotu A
    Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and diabetes: inhibition of amylin aggregation by nonsteroidal anti-inflammatory drugs.
    Thomas T; Nadackal GT; Thomas K
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):8-11. PubMed ID: 12605343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of the endocrine pancreas: the central role of amylin and insulin resistance.
    Hayden MR; Tyagi SC
    South Med J; 2000 Jan; 93(1):24-8. PubMed ID: 10653060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave assisted SPPS of amylin and its toxicity of the pure product to RIN-5F cells.
    Muthusamy K; Albericio F; Arvidsson PI; Govender P; Kruger HG; Maguire GE; Govender T
    Biopolymers; 2010; 94(3):323-30. PubMed ID: 20069542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
    Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
    FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet pathology of non-insulin-dependent diabetes mellitus (NIDDM).
    Westermark P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S46-8. PubMed ID: 8894481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is islet amyloid polypeptide a significant factor in pathogenesis or pathophysiology of diabetes?
    Steiner DF; Ohagi S; Nagamatsu S; Bell GI; Nishi M
    Diabetes; 1991 Mar; 40(3):305-9. PubMed ID: 1999269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
    Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
    Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane permeabilization by Islet Amyloid Polypeptide.
    Engel MF
    Chem Phys Lipids; 2009 Jul; 160(1):1-10. PubMed ID: 19501206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the heparin binding site in the N-terminus of human pro-islet amyloid polypeptide: implications for amyloid formation.
    Abedini A; Tracz SM; Cho JH; Raleigh DP
    Biochemistry; 2006 Aug; 45(30):9228-37. PubMed ID: 16866369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amylin, islet amyloid and diabetes mellitus type II].
    Fehmann HC; Göke B
    Dtsch Med Wochenschr; 1990 Nov; 115(46):1769-72. PubMed ID: 2226190
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyloidosis of pancreatic islets in primary amyloidosis (AL type).
    Tomita T
    Pathol Int; 2005 Apr; 55(4):223-7. PubMed ID: 15826250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers.
    Sparr E; Engel MF; Sakharov DV; Sprong M; Jacobs J; de Kruijff B; Höppener JW; Killian JA
    FEBS Lett; 2004 Nov; 577(1-2):117-20. PubMed ID: 15527771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.